Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

INTRODUCTION: Serial alterations in protein C levels appear to correlate with disease severity in patients with severe sepsis, and it may be possible to tailor severe sepsis therapy with the use of this biomarker. The purpose of this study was to evaluate the dose and duration of drotrecogin alfa (a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shorr, Andrew F, Janes, Jonathan M, Artigas, Antonio, Tenhunen, Jyrki, Wyncoll, Duncan LA, Mercier, Emmanuelle, Francois, Bruno, Vincent, Jean-Louis, Vangerow, Burkhard, Heiselman, Darell, Leishman, Amy G, Zhu, Yajun E, Reinhart, Konrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219981/
https://www.ncbi.nlm.nih.gov/pubmed/21176144
http://dx.doi.org/10.1186/cc9382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219981/
https://www.ncbi.nlm.nih.gov/pubmed/21176144
http://dx.doi.org/10.1186/cc9382

Ejemplares similares